Literature DB >> 33229384

Dexamethasone or hydrocortisone in COVID-19?

Chia Siang Kow1, Syed Shahzad Hasan2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33229384     DOI： 10.3949/ccjm.87c.12005

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


× No keyword cloud information.
  4 in total

Review 1.  Involvement of Interleukin-1 Receptor-Associated Kinase 4 and Interferon Regulatory Factor 5 in the Immunopathogenesis of SARS-CoV-2 Infection: Implications for the Treatment of COVID-19.

Authors:  Nicholas Stoy
Journal:  Front Immunol       Date:  2021-04-07       Impact factor: 7.561

2.  [Glucocorticoid therapy in patients with COVID-19 and concurrent heart failure].

Authors:  C S Kow; D S Ramachandram; S S Hasan
Journal:  Rev Clin Esp       Date:  2021-11-20       Impact factor: 3.064

3.  Methylprednisolone Pulses in Hospitalized COVID-19 Patients Without Respiratory Failure: A Randomized Controlled Trial.

Authors:  Iñigo Les; Jose Loureiro-Amigo; Ferran Capdevila; Isabel Oriol; Iñaki Elejalde; Judit Aranda-Lobo; Joao Modesto; Elena Güell-Farré; Ruth García; Anna Murgadella-Sancho; Javier Anniccherico; Miguel Martín-Fernández; José Javier Lorza; Joan-Pol Monteys-Montblanch; Julián Librero; Sara Pintado-Lalueza; Marina Delgado; Berta Gracia-García; Julio Sánchez-Álvarez; Melani Pestaña-Fernández; Patricia Fanlo; Gisela Funalleras-Puig; Maite Sarobe; Eduardo Mediavilla; Carlos Ibero
Journal:  Front Med (Lausanne)       Date:  2022-02-28

4.  Glucocorticoid therapy in patients with COVID-19 and concurrent heart failure.

Authors:  C S Kow; D S Ramachandram; S S Hasan
Journal:  Rev Clin Esp (Barc)       Date:  2022-01-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.